Various catalytically active IgG antibodies or abzymes have been recently detected in the sera of patients with several autoimmune pathologies, where their presence is most probably associated with autoimmunization. Here we show for the first time that IgG from peripheral blood of patients with Hashimoto's thyroiditis and nontoxic nodal goiter possesses DNase activity. The properties of the DNase IgGs distinguished them from other known human DNases. The findings give an evidence in favor of the generation of polyclonal catalytic IgG by the immune system of individual patients with impaired function of the thyroid glands. The relative level of specific activity of IgGs in hydrolysis of DNA increases with the elevation of the relative amount of antibodies against thyroglobulin and with the decrease of thyroid hormone concentrations. All patients with hypothyroidism are characterized by a high level of catalytic antibodies, while elevation of functional activity of the thyroid gland and improvement of the clinical state of the patients lead to decrease of the antibody's enzymic activity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

igg antibodies
8
sera patients
8
patients hashimoto's
8
hashimoto's thyroiditis
8
thyroiditis nontoxic
8
nontoxic nodal
8
nodal goiter
8
patients
6
comparison level
4
level dna-hydrolyzing
4

Similar Publications

Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders.

Neurol Neuroimmunol Neuroinflamm

March 2025

Neuroimmunology Laboratory and Neuroimmunology Research Section, IRCCS Mondino Foundation, Pavia, Italy.

Background And Objectives: Antibodies to proteolipid protein-1 (PLP1-IgG), a major central myelin protein also expressed in the peripheral nervous system (PNS) as the isoform DM20, have been previously identified mostly in patients with multiple sclerosis (MS), with unclear clinical implications. However, most studies relied on nonconformational immunoassays and included few patients with non-MS CNS autoimmune demyelinating disorders (ADDs). We aimed to investigate conformational PLP1-IgG in the whole ADD spectrum.

View Article and Find Full Text PDF

Introduction: The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republika Srpska, Bosnia and Herzegovina, after five waves of COVID-19 and 1 year after introduction of vaccination to better understand the true extent of the COVID-19 pandemic in the population of the Republika Srpska and role of vaccination in achieving herd immunity.

Methods: The population-based study was conducted from December 2021 to February 2022 in a group of 4463 individuals in the Republika Srpska. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the Wantai total antibody ELISA assay.

View Article and Find Full Text PDF

Serial intrauterine transfusion for severe fetal anemia due to anti-M alloimmunization.

Asian J Transfus Sci

September 2022

Department of Obstetrics and Gynecology, Faculty of Medicine Padjajaran University, Hasan Sadikin General Hospital, Bandung, Indonesia.

Anti-M antibody is one of the causes of severe fetal anemia and intrauterine death despite its relatively low frequency. A G3P2 26-year-old pregnant woman referred to our hospital at 29 weeks gestational age (WGA) with fetal hydrops. Her second pregnancy results in intrauterine fetal death at 35 WGA due to fetal hydrops.

View Article and Find Full Text PDF

ABO isoagglutinin titers in group "O" blood donors.

Asian J Transfus Sci

October 2024

Department of Transfusion Medicine, Sri Balaji Action Medical Institute, New Delhi, India.

Background: High titers of anti-A and anti-B are considered to be one reason for hemolytic transfusion reactions and ABO hemolytic disease in fetus and neonates. There is no consensus for critical ABO antibody titers to guide transfusion or transplant decisions. Implementation of ABO titer measurement can favor reduction in transfusion reactions in nongroup "O" recipients.

View Article and Find Full Text PDF

Hemolytic disease of foetus and newborn (HDFN) is a disease characterized by the destruction of fetal red cells by the maternal antibodies which occurs due to allo immunization in the mother by feto-maternal blood group incompatibility. The antibodies most frequently implicated in HDFN may vary depending on the demographic location under consideration. In areas where RhIg administration is available, ABO antibodies are more commonly implicated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!